Laboratorios Lesvi, S.l.

Carmen Ubeda Perez

Pablo Pablo Alba

Ignacio Diez Martin

Anna Ruiz Amenos

The invention relates to a solid formulation for the oral administration of olanzapine that comprises a core of anhydrous olanzapine Form I or a pharmaceutically acceptable salt thereof and, optionally, pharmaceutically acceptable excipients, said core being coated with a functional polymer that acts as filmogenic agent. The method for obtaining it comprises: i) providing anhydrous olanzapine Form I or a salt thereof and, optionally, pharmaceutically acceptable excipients in solid form; ii) providing a functional polymer that acts as filmogenic agent; iii) preparing a dispersion of said functional polymer in an aqueous medium,&#x2014;and applying the dispersion obtained in step iii) onto the solid form of step i).

Growing community of inventors

Cabrils, Spain

Carmen Ubeda Perez